These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31120285)

  • 1. Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research.
    Nona CN; Hendershot CS; Le Foll B
    Exp Clin Psychopharmacol; 2019 Aug; 27(4):359-369. PubMed ID: 31120285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THC and CBD effects on alcohol use among alcohol and cannabis co-users.
    Karoly HC; Mueller RL; Andrade CC; Hutchison KE
    Psychol Addict Behav; 2021 Sep; 35(6):749-759. PubMed ID: 33764086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
    Hempel BJ; Clasen MM; Nelson KH; Woloshchuk CJ; Riley AL
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):205-213. PubMed ID: 29648861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.
    Jacobs DS; Kohut SJ; Jiang S; Nikas SP; Makriyannis A; Bergman J
    Exp Clin Psychopharmacol; 2016 Oct; 24(5):320-330. PubMed ID: 27690502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
    Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
    Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of interaction between delta9-tetrahydrocannabinol (delta-THC) and cannabidiol (CBD) in aggression, muscle control and body temperature experiments in mice.
    Ham MT; De Jong Y
    Psychopharmacologia; 1975; 41(2):169-74. PubMed ID: 1171491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition.
    Colizzi M; Bhattacharyya S
    Curr Addict Rep; 2017; 4(2):62-74. PubMed ID: 28580227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review.
    Turna J; Syan SK; Frey BN; Rush B; Costello MJ; Weiss M; MacKillop J
    Alcohol Clin Exp Res; 2019 Apr; 43(4):550-563. PubMed ID: 30698831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition.
    Colizzi M; Ruggeri M; Bhattacharyya S
    Front Psychol; 2020; 11():833. PubMed ID: 32528345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
    Stern CA; Gazarini L; Vanvossen AC; Zuardi AW; Galve-Roperh I; Guimaraes FS; Takahashi RN; Bertoglio LJ
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):958-65. PubMed ID: 25799920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.
    Arellano AL; Papaseit E; Romaguera A; Torrens M; Farré M
    CNS Neurol Disord Drug Targets; 2017; 16(5):554-566. PubMed ID: 28412920
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Pellati F; Borgonetti V; Brighenti V; Biagi M; Benvenuti S; Corsi L
    Biomed Res Int; 2018; 2018():1691428. PubMed ID: 30627539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
    Zlebnik NE; Cheer JF
    Annu Rev Neurosci; 2016 Jul; 39():1-17. PubMed ID: 27023732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between cannabidiol and Δ
    Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC
    Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cannabidiol (CBD) on Δ⁹-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats.
    Wakeford AGP; Wetzell BB; Pomfrey RL; Clasen MM; Taylor WW; Hempel BJ; Riley AL
    Exp Clin Psychopharmacol; 2017 Aug; 25(4):242-248. PubMed ID: 28682102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
    Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
    Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the antipsychotic properties of cannabidiol in humans.
    Iseger TA; Bossong MG
    Schizophr Res; 2015 Mar; 162(1-3):153-61. PubMed ID: 25667194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.